(Q42934763)

English

Imatinib mesylate has the potential to exert its efficacy by down-regulating the plasma concentration of platelet-derived growth factor in patients with pulmonary arterial hypertension

scientific article published on July 2010

Statements

Imatinib mesylate has the potential to exert its efficacy by down-regulating the plasma concentration of platelet-derived growth factor in patients with pulmonary arterial hypertension (English)
1 July 2010
272-276

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit